Based in Tennessee, next-generation Medicare Advantage insurer Clover Health (NASDAQ:CLOV) is on a mission to improve every life. Hopefully, that would include the shareholders, although CLOV stock admittedly hasn’t performed well over the past six months. Currently, the stock is down 65% for that period.
Granted, CLOV did generate plenty of buzz during the summer of 2021. Apparently, Reddit-using retail traders targeted Clover Health for a short squeeze. Some folks undoubtedly made money from that trade.
On the other hand, though, long-term CLOV shareholders are probably frustrated at the recent price decline. Can they count on a recovery in 2022?
Read more about CLOV stock here
This post appeared first on InvestorPlace.